Analysis of cis-acting sequences required for operation of the erythropoietin 3' enhancer in different cell lines.
Pugh
C W
CW
Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom.
Ebert
B L
BL
Ebrahim
O
O
Maxwell
P H
PH
Ratcliffe
P J
PJ
D000818:Animals; D001483:Base Sequence; D006528:Carcinoma, Hepatocellular; D015687:Cell Hypoxia; D002460:Cell Line; D004742:Enhancer Elements, Genetic; D004921:Erythropoietin / Q000096:biosynthesis* / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms; D051379:Mice; D008969:Molecular Sequence Data; D012045:Regulatory Sequences, Nucleic Acid; D012689:Sequence Homology, Nucleic Acid; D014158:Transcription, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured
D004921:Erythropoietin